Probiotic Treatment of Ulcerative Colitis With Trichuris Suis Ova (TSO)
The PROCTO trial is a double-blind randomized, placebo-controlled, 24-week, comparative, exploratory phase II proof of concept trial. The trial will be conducted with 2 treatment groups as a parallel group comparison and will serve to compare a 7500 TSO regimen vs. placebo for achieving clinically meaningful responses in Ulcerative Colitis.
100 Clinical Results associated with PARATECH Co., Ltd.
0 Patents (Medical) associated with PARATECH Co., Ltd.
100 Deals associated with PARATECH Co., Ltd.
100 Translational Medicine associated with PARATECH Co., Ltd.